Treating cervical cancer in future may take just 30 seconds thanks to a futuristic-looking device. The technology, recently recommended by WHO, was introduced in Uzbekistan at a WHO training course preparing the country’s health professionals to use the new equipment in outpatient clinics.

For those who need treatment of cervical precancerous lesions, the new therapy will be available in 2 of Uzbekistan’s regions, where 56 000 women are participating in the country’s first human papillomavirus (HPV)-based cervical cancer screening pilot project.

In the WHO European Region, 30 000 women die from cervical cancer every year. Virtually all cervical cancer cases (99%) are caused by genital infection with oncogenic types of HPV.

For more, click below.